E-LIB Suche - Ergebnisse für: Shimada, Fumiki

1

Interim Results of Post-Marketing Observational Study of Om..:

Nakazawa, Toru ; Takahashi, Kanji ; Kuwayama, Yasuaki..
Advances in Therapy. 39 (2022) 3 - p. 1359-1374 , 2022

Link: https://doi.org/10.1007/..

2

Long-Term Safety and Effectiveness of Diquafosol for the Tr..:

Ohashi, Yuichi ; Munesue, Masahiro ; Shimazaki, Jun...
Advances in Therapy. 37 (2019) 2 - p. 707-717 , 2019

Link: https://doi.org/10.1007/..

3

The clinical effectiveness of tafluprost on Japanese normal..:

Nomura, Akio ; Osaki, Hirotaka ; Shimada, Fumiki.
Clinical Ophthalmology. 12 (2018) - p. 539-548 , 2018

Link: https://doi.org/10.2147/..

4

Prospective Observational Post-Marketing Study of Taflupros..:

Kuwayama, Yasuaki ; Hashimoto, Masako ; Kakegawa, Reiko..
Advances in Therapy. 34 (2017) 6 - p. 1411-1425 , 2017

Link: https://doi.org/10.1007/..

5

Safety of Gadopentetate Dimeglumine after 120 Million Admin..:

MATSUMURA, Toru ; HAYAKAWA, Masakane ; SHIMADA, Fumiki...
Magnetic Resonance in Medical Sciences. 12 (2013) 4 - p. 297-304 , 2013

Link: https://doi.org/10.2463/..

6

Regenerative Medicine and Stem Cell Based Drug Discovery:

Sakurada, Kazuhiro ; McDonald, Fiona M. ; Shimada, Fumiki
Angewandte Chemie International Edition. 47 (2008) 31 - p. 5718-5738 , 2008

Link: https://doi.org/10.1002/..

7

Activation of adenosine A1receptor-induced neural stem cell..:

Migita, Hideyuki ; Kominami, Katsuya ; Higashida, Mami...
Journal of Neuroscience Research. 86 (2008) 13 - p. 2820-2828 , 2008

Link: https://doi.org/10.1002/..

8

Heterogeneity of pluripotent marker gene expression in colo..:

Masaki, Hideki ; Ishikawa, Tetsuya ; Takahashi, Shunichi...
Stem Cell Research. 1 (2008) 2 - p. 105-115 , 2008

Link: https://doi.org/10.1016/..

9

Regenerative Medizin und stammzellbasierte Wirkstoffentwick..:

Sakurada, Kazuhiro ; McDonald, Fiona M. ; Shimada, Fumiki
Angewandte Chemie. 120 (2008) 31 - p. 5802-5823 , 2008

Link: https://doi.org/10.1002/..

10

The neuroprotective agent MS-153 stimulates glutamate uptak:

Shimada, Fumiki ; Shiga, Yoshio ; Morikawa, Maki...
European Journal of Pharmacology. 386 (1999) 2-3 - p. 263-270 , 1999

Link: https://doi.org/10.1016/..

11

Enhancing effect of MS-153, a neuroprotective agent, on glu..:

Shimada, Fumiki ; Shirai, Yasuhito ; Morikawa, Osamu.
Neuroscience Research. 31 (1998) - p. S91 , 1998

Link: https://doi.org/10.1016/..

12

Cerebroprotective effect of MS-153 after reperfusion or per..:

Shiga, Yoshio ; Shimada, Fumiki ; Fukui, Yasuhiro.
Japanese Journal of Pharmacology. 73 (1997) - p. 245 , 1997

Link: https://doi.org/10.1016/..

13

Inhibitory effect of MS-153, a cerebroprotective agent, on ..:

Shimada, Fumiki ; Sakata, Kazuhiko ; Shiga, Yoshio...
Japanese Journal of Pharmacology. 73 (1997) - p. 245 , 1997

Link: https://doi.org/10.1016/..

14

Effect of MS-153, a cerebroprotective agent, on γ protein k..:

Sakata, Kazuhiko ; Morikawa, Maki ; Fukui, Yasuhiro...
Japanese Journal of Pharmacology. 73 (1997) - p. 246 , 1997

Link: https://doi.org/10.1016/..

15

Cerebroprotective Effects of a Novel Pyrazoline Derivative,..:

Kawazura, Hiroshi ; Takahashi, Yasuhiro ; Shiga, Yoshio...
Japanese Journal of Pharmacology. 73 (1997) 4 - p. 317-324 , 1997

Link: https://doi.org/10.1254/..